Price
$9.83
Decreased by -0.20%
Dollar Volume
10.88 M
ADR%
0.38
Earnings Report Date (estimate)
Feb 20, 23 (-0.21)
Market Cap.
467.41 M
Shares Float
28.72 M
Shares Outstanding
47.55 M
Beta
2.36
Price / Earnings
-11.58
BPR
408.96
20D Range
9.81 9.97
50D Range
5.66 10.30
200D Range
3.49 10.30
  • Quarterly Earnings
  • Annual Earnings
Reported Date EPSChange YoY EstimateSurprise
Nov 1, 22 -0.28
Decreased by -21.74%
-0.23
Decreased by -21.74%
Aug 2, 22 -0.26
Decreased by -136.36%
-0.22
Decreased by -18.18%
May 3, 22 -0.21
Decreased by -23.53%
-0.20
Decreased by -5.00%
Feb 22, 22 -0.27
Decreased by -92.86%
-0.19
Decreased by -42.11%
Nov 1, 21 -0.23
Decreased by -109.09%
-0.28
Increased by +17.86%
Aug 3, 21 -0.11
Increased by +63.33%
-0.20
Increased by +45.00%
May 4, 21 -0.17
Increased by +65.31%
-0.22
Increased by +22.73%
Feb 25, 21 -0.14
Increased by +58.82%
-0.25
Increased by +44.00%
  • Quarterly Financials
  • Annual Financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Sep 30, 22 19.57 M
Increased by +19.71%
-11.45 M
Decreased by -71.94%
Decreased by -58.48%
Decreased by -43.64%
Jun 30, 22 19.31 M
Increased by +16.24%
-10.43 M
Decreased by -245.35%
Decreased by -54.00%
Decreased by -197.10%
Mar 31, 22 16.66 M
Increased by +20.24%
-8.41 M
Decreased by -82.87%
Decreased by -50.50%
Decreased by -52.09%
Dec 31, 21 16.17 M
Increased by +25.75%
-10.40 M
Decreased by -196.86%
Decreased by -64.34%
Decreased by -136.08%
Sep 30, 21 16.35 M
Increased by +27.48%
-6.66 M
Decreased by -156.33%
Decreased by -40.71%
Decreased by -101.07%
Jun 30, 21 16.61 M
Increased by +194.29%
-3.02 M
Increased by +51.72%
Decreased by -18.18%
Increased by +83.59%
Mar 31, 21 13.86 M
Increased by +29.29%
-4.60 M
Increased by +55.14%
Decreased by -33.20%
Increased by +65.30%
Dec 31, 20 12.86 M
Increased by +7.26%
-3.50 M
Increased by +51.29%
Decreased by -27.26%
Increased by +54.59%
  • Top 20 ETF Stock Exposure
  • Top 20 Institutional Holders
  • Top 20 Mutual Fund Holders
Rank ETF Shares Market Value Weight % in ETF
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY

Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to sutures and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, as well as delays gastric content emptying under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands. Additionally, the company offers X-Tack Endoscopic HeliX Tacking System, a suture-based device for closing and healing defects in the lower and upper gastrointestinal tract. The company sells its products to medical services providers; and hospitals, outpatient surgical centers, clinics, and physicians in the United States, Australia, Costa Rica, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas.